Related Experiment Video
Updated: Jun 7, 2025

A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
A Missing Mechanism of Effect: How People Who Habitually Replot Stories React Differently (Or Not so Differently) to
Helen M Lillie1, Manusheela Pokharel2, Jakob D Jensen3
1Department of Communication Studies, University of Iowa, Iowa City, Iowa, USA.
Abstract:
When stories have undesirable endings, readers often engage in replotting, meaning they imagine alternative plotlines that could change the unwanted ending. Recent research has found that both the cognitive and emotional components of replotting serve as mechanisms of narrative persuasion. Building on this work, the current study assessed if people who habitually replot are more persuaded by a tragic story ending than those who do not, testing hypotheses with melanoma narratives. Cognitive and emotional (i.e., anger, anxiety, sadness, and hope) aspects of replotting were tested as mechanisms of this proposed interaction. Participants (N = 432) were randomized into a 2 (protagonist death vs. survival) x 6 (specific melanoma story) between-subjects online narrative message experiment. Participants who habitually replot had significantly higher melanoma prevention intentions after reading a death (compared to a survival) ending. This effect was not present for other participants. However, counter to hypotheses, the cognitive and emotional aspects of actual replotting did not explain the effect, meaning habitual replotters were not more likely to replot the death ending or experience replotting emotion than other participants were. Future research is needed to determine why habitual replotters are more persuaded by unwanted story endings than other audience members are.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

